Publication Date: December 2004
Publisher: Food and Drug Law Institute (U.S.)
Author(s): Kathy Hudson; Gail Javitt
Research Area: Health
Keywords: FDA regulation; Reproductive genetics; Cloning; Genetics
Coverage: United States
Since 1998, the Food and Drug Administration (FDA) has stated publicly that it has jurisdiction to regulate human reproductive cloning. Consistent with this position, the agency sent letters to researchers informing them of the need to submit an investigational new drug (IND) application before clinical efforts to clone a human being. Further, FDA has stated that, because human reproductive cloning raises currently unresolved safety concerns, the agency will not approve such an application until those concerns are addressed appropriately. In this way, FDA, in effect, has banned human reproductive cloning.